ROSEN, a well-established legal firm, advises investors of Altimmune, Inc. to seek legal representation before the approaching deadline in the securities class action lawsuit.
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and…